In Cbl metabolism-defective patients, clinical features included acute neurologic deterioration, developmental delay, lethargy, hypotonia and feeding problems in neonatal (< 1 month old) and early onset patients (< 1 year of life). The gene discussed is CBL; the disease is Global developmental delay.